The Trump administration is investigating pharmaceutical and semiconductor imports for potential tariffs under Section 232. This follows recent tariff exclusions for electronics. The investigations aim to boost domestic production of these goods. Economists warn that the tariffs will negatively impact the US economy, causing job losses and inflation. The probes could lead to significant changes in the industry.
